Liver Diseases | Cirrhosis | Japan | Gastroenterology | Hepatitis

Theme: Exploring the futuristic innovations and praxis to enrich Liver Health

Liver Diseases 2019

Liver Diseases 2019

"Liver is the driving force to run the entier system, so keep it healthy".

Conference Series cordially welcomes you to attend the “10th International Congress on Liver Diseases & Hepatology (Liver Diseases 2019)” which scheduled on December 02-03, 2019 in Tokyo, Japan. The main objective of the conference is to bring together leading academicians, scientists, researchers, graduate students and business delegates from the field of medical (Gastroenterologists, Hepatologists, Nephrologists, Pathologists, Virologists, Oncology) environmental specialist & pharmaceutical specialist and others from all over the world. Liver Diseases 2019 is a two days conference organized by Organizing Committee Members where it starts with a keynote session followed by an oral presentation and poster presentations and final ends with the certificate distribution.

Hepatology is the study of Liver, gall bladder, biliary tree and pancreas and its disorders. This is the best chance for all the doctors as well as scientific researchers and students to find out the new techniques in Hepatology and find out the different ways of treatments to be given to the patients affected with Hepatitis. So, don’t miss the opportunity and be a part of it as the new era begins.

With members from around the world focused on learning about Liver Diseases and Hepatology. This is your best opportunity to reach the largest assemblage of participants from the Hepatology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Liver Diseases and Hepatology, treatment and surgery involved are hallmarks of this conference.

Scope of the Conference:

Liver Diseases conference 2019 provides a great platform to grow your connections by gathering eminent people like professors, Researchers, scientists, industrialists, Students and delegates to exchange new ideas and knowledge. This conference is mainly focusing on a wide range of topics and allows participants to discuss about the management of liver diseases and Hepatitis. Liver Diseases conference 2019 conference consists of keynote and plenary lectures, special sessions (Workshop and Symposium), Young Researcher Forum and Poster presentations. Best poster presenters and video presenters will be judged and awarded during the conference. We encourage a broad participation from all over the world, Conference Series Ltd main motive is to spread the knowledge and exchange the ideas to build a smart and infectious free world.

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Best Poster Award)
Young Researcher Forum (YRF Award best presenter)
Student Attendee
Group Registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

Targeted Audience:

Gastroenterologists
Hepatologists
Pathologists
Gynecologists
Radiologists
Oncologists
Research scholars
Doctors and General Physicians
Biotechnology and Bioinformatics students
Deans and Professors of Medicine & Hepatology departments
Professors & Students from cancer research centres
R&D department in pharmacy
Clinical Development Physicians, Researchers & Scientists
Public Health Professional
Medical Equipment Manufacturers
Hospitals and Health Services
Medical & Health care Organizations & Associations
Pancreas and Liver research institutes
Nurse and nursing education institutions
Medical Colleges
Business Professionals
Distributors/Sales Representatives
Pharmaceutical Companies
Cancer research universities in Asia-pacific regions

It's our right to keep our liver healthy because it's our's

Track 1: Liver Diseases

The liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. There are over 100 different forms of liver disease that affect men, women and children. These diseases include cirrhosis, alcohol abuse, hepatitis A, B, C, D, and E, Epstein Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease and iron overload (hemochromatosis). The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discolouration of the skin (jaundice).

Related liver Diseases and Hepatology Conferences:

16th World Congress on Gastroenterology & Therapeutics July 22-23, 2019 Osaka, Japan | 19th International Conference on Gastroenterology and Hepatology | November 18-19, 2019 | Abu Dhabi, UAE | Physicians Meet on Gastroenterology and Digestive Disorders Conference | August 14-15, 2019 | Auckland, New Zealand | 2nd World Summit on Liver Cirrhosis and Hepatitis September 23-24, 2019 Tokyo, Japan | 10th International Congress on Liver Diseases & Hepatology | December 02-03, 2019 | Tokyo, Japan | 15th Annual Congress on Gastroenterology & Hepatology | September 27-28, 2019 Hong Kong

Track 2: Inherited Liver Diseases

Inherited Liver Diseases are genetically transferred from ancestors to the parents, grandchildren.
The most important and chronic hereditary liver diseases vary from person to the person. Now a day’s scientists are telling that liver cancer is also a hereditary disease.

Important inherited disorders causing acute and chronic liver diseases include hemochromatosis, Wilson's disease, alpha 1-antiprotease and cystic fibrosis. Important inherited disorders causing acute and chronic liver disease include hemochromatosis, Wilson's disease, alpha 1-antiprotease (antitrypsin) deficiency, and cystic fibrosis. Alpha 1-antiprotease is due to deficiency of antitrypsin.

Related liver Diseases and Hepatology Conferences:

Track 3: Liver and Biliary

The liver is the largest gland in the body and conducts a myriad of vital metabolic and excretory functions. In addition, by virtue of its circulatory relationship to the absorptive surface of the gastrointestinal tract, the liver is the initial site where ingested nutrients, and other substances entering via the gastrointestinal tract, such as drugs and bacterial metabolites, are processed by the body. Thus, the liver is a gate-keeper that can process useful substances while detoxifying orally absorbed substances that are potentially harmful, such as toxic xenobiotics.

Related liver Diseases and Hepatology Conferences:

Track 4: Liver Cirrhosis

Cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism. Cirrhosis occurs in response to damage to your liver. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As cirrhosis progresses, more and more scar tissue forms, making it difficult for the liver to function. Cirrhosis occurs in response to damage to your liver. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As cirrhosis progresses, more and more scar tissue forms, making it difficult for the liver to function which include Fluid accumulation in your abdomen (ascites), Confusion, drowsiness and slurred speech (hepatic encephalopathy), Testicular atrophy in men, Breast enlargement in men. Cirrhosis can also cause portal hypertension, Enlargement of the spleen (splenomegaly).

Related liver Diseases and Hepatology Conferences:

Track 5: Hepato-Radiology

Liver imaging is basically for precise diagnosing biliary tract issue and is imperative for identifying liver injuries or damage and patients with a suspected malignancy is important because the liver is the common site of metastatic spread and those who are at the risk of developing hepatocellular carcinoma.

Related liver Diseases and Hepatology Conferences:

Track 6:: Liver Injury and Immune Responses

Hepatic irritation is a typical finding amid an assortment of liver sicknesses including drug-prompted liver poisonous quality. The provocative phenotype can be credited to the intrinsic safe reaction produced by Kupffer cells, monocytes, neutrophils, and lymphocytes. The versatile invulnerable framework is additionally affected by the intrinsic resistant reaction prompting liver harm.

Related liver Diseases and Hepatology Conferences:

Track 7:Liver Function

The liver is the body’s largest internal organ that sits on the right-hand side of the belly. It is an essential organ that has many functions in the body, including making proteins and blood clotting factors, manufacturing triglycerides and cholesterol, glycogen synthesis and bile production. The liver filters the blood coming from the digestive tract and detoxifies the chemicals and metabolizes the vitamins, proteins, fats, carbohydrates and drugs. The liver secretes the bile that ends up back in the intestine.

Related liver Diseases and Hepatology Conferences:

Track 8: Hepato-Nephrology and Pathology

Liver pathology is altered in HRS while kidney histology is normal. It is a trichrome stain (chicken wire appearance) cirrhosis of the liver, the most common cause of HRS. The diagnosis of hepatorenal syndrome is depends on laboratory tests of individuals susceptible conditions.

Hepato-renal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dialysis, can prevent advancement of the condition.

HRS can affect individuals with cirrhosis, severe alcoholic hepatitis, or liver failure, and usually occurs when liver function deteriorates rapidly because of a sudden insult such as an infection, bleeding in the gastrointestinal tract, or overuse of diuretic medications.

Related liver Diseases and Hepatology Conferences:

Track 9: Hepatitis and its Types

Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis.

There are 5 main hepatitis viruses, referred to as types Hepatitis A (HAV), Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis D (HDV) and Hepatitis E (HEV). These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. Types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer.

Related liver Diseases and Hepatology Conferences:

Track 10: Hepatitis, Liver Diseases and Pregnancy

Intense viral hepatitis is the most widely recognized reason for jaundice in pregnancy. The course of most popular contaminations isn't influenced by pregnancy. Jaundice is a trademark highlight of the liver malady. The clinical signs and side effects are unclear between the different types of viral hepatitis, subsequently, the differential determination requires serologic testing for an infection conclusion, and the finding is by a biochemical appraisal of liver capacity.

Related liver Diseases and Hepatology Conferences:

Track 11:: Hepatitis: Screening and Testing Methods

The disclosure of hepatitis infection (HV) has prompted the advancement of serological tests for the discovery of counteracting agent to this newfound infection. Gatherings at more serious danger of obtaining HV contamination incorporate intravenous medication clients, haemodialysis patients, haemophiliacs and blood transfusion beneficiaries. The screening of blood givers for hostile to HV has incredibly diminished the rate of post-transfusion hepatitis. One of the real issues with HV disease is the advancement of endless hepatitis in 50 to 60% of cases, which could prompt cirrhosis and hepatocellular carcinoma.

Related liver Diseases and Hepatology Conferences:

Track 12:Prevention and Treatment for Hepatitis

To diagnose hepatitis, first, your doctor will take your history to determine any risk factors you may have for infectious or non-infectious hepatitis. Liver function tests use blood samples to determine how efficiently your liver works.

High liver enzyme levels may indicate that your liver is stressed, damaged, or not functioning properly. An abdominal ultrasound uses ultrasound waves to create an image of the organs within your abdomen. It can reveal Liver tumours, Liver failure, Abnormalities of the gall bladder. Treatment options are determined by which type of hepatitis you have and whether the infection is acute or chronic.

Related liver Diseases and Hepatology Conferences:

Track 13: Liver Transplantation and surgery

Liver transplant is an operation that replaces a replaces a person’s diseased heart with a partial or a whole liver from a donor. A rare condition in new-born infants is Biliary atresia in which the common bile ducts, which carry bile out of liver and present between the liver and small intestine is absent or blocked. Bariatric surgery performed on people, who have obesity through a variety of procedures. Removing a tissue sample (biopsy) from the liver may help diagnose liver disease. Liver biopsy is done using a long needle inserted through the skin to extract a tissue sample and then analysed in a laboratory.

Related liver Diseases and Hepatology Conferences:

Track 14: Stem cell treatment on Liver Diseases

Cell therapy is an emerging approach being tested in this setting. Hepatocytes are the principal cells of the liver parenchyma and are responsible for maintaining liver function. They can originate from three sources. In a normal liver, hepatocytes themselves can proliferate to restore the functional liver mass, a mechanism that could be compromised in cirrhosis. Second, the liver contains liver progenitor cells that can also proliferate and differentiate into hepatocytes.

Chronic liver diseases can lead to cirrhosis, characterised by fibrous septa dissecting the liver parenchyma, affecting both liver function (due to reduced functional mass) and normal intrahepatic venous pressure (due to increased stiffness). Antiviral treatment for hepatitis B or C virus infection, alcohol abstinence for alcohol-related liver disease, or weight loss strategies for metabolic non-alcoholic fatty liver disease, whereas other causes remain difficult to treat (like genetic disorders or autoimmune problems).

Related liver Diseases and Hepatology Conferences:

Track 15: Hepatology and Nutrition

Gastroenterology, Hepatology and Nutrition the team of pediatric gastroenterologists, hepatologists, dietitians, clinicians and nurses are dedicated to helping children with common or complex gastrointestinal, liver and nutritional problems. The goals of the Gastroenterology Division are to provide outstanding medical care to persons with diseases of the gastrointestinal tract and liver, to train gastroenterology and to perform cutting-edge biomedical research to improve our understanding of digestive diseases.

Related liver Diseases and Hepatology Conferences:

Track 16:Hepatitis Vaccination

The best way to prevent hepatitis is by getting the hepatitis vaccines. Vaccination is safe and effective, and it is recommended for all. Efforts to develop a hepatitis C vaccine started more than 20 years ago, when the hepatitis C virus was identified. The hepatitis C virus is more variable than are the viruses that cause hepatitis A and hepatitis B. Hepatitis C virus occurs in at least six genetically distinct forms with 50 subtypes. A global vaccine would have to protect against all these variants of the virus.

Related liver Diseases and Hepatology Conferences:

Track 17: Hepatocellular Carcinoma and Transarterial Chemo-Embolization

Hepatocellular carcinoma (HCC) is the most widely recognized kind of essential liver growth in grown-ups and is the most well-known reason for death in individuals with cirrhosis. It happens in the setting of incessant liver aggravation and is most firmly connected to endless viral hepatitis contamination (hepatitis B or C) or introduction to poisons, for example, liquor or Aflatoxin. Certain ailments, for example, hemochromatosis and alpha 1-antitrypsin lack, particularly increment the danger of treating HCC. Similarly, as with any malignancy, the treatment and forecast of HCC differ contingent upon the specifics of tumour histology, measure, how far growth has spread, and in general wellbeing.

Related liver Diseases and Hepatology Conferences:

Track 18: Liver Biopsy

A liver biopsy is a procedure in which a small needle is inserted into the liver to collect a tissue sample. This is performed as an office or outpatient procedure or during surgery. The tissue is then analyzed in a laboratory to help doctors diagnose a variety of diseases and disorders in the liver. In most instances, there are no complications in obtaining a liver biopsy. However, rarely internal bleeding may occur, as well as a leak of bile from the liver or gallbladder.

Related liver Diseases and Hepatology Conferences:

Track 19: Clinical Trials on Hepatology

Liver resection is the surgical removal of all or a portion of the liver. It is also referred to as a hepatectomy, full or partial. Complete liver resection is performed in the setting of a transplant a diseased liver is removed from a deceased donor (cadaver). A living donor may also provide a piece of liver tissue which is procured through a partial hepatectomy. The procedure may be performed through a traditional open procedure or using minimally invasive techniques.

Related liver Diseases and Hepatology Conferences:

Track 20: Gastroenterology

Gastroenterology is mainly dealing with the regulation and function from Mouth to the anus, and their disorders. It contains a complete comprehension of their activity (physiology) of the gastrointestinal organs containing the program of material through the stomach and digestive system (motility), the assimilation and ingestion of supplements into the body, expulsion of waste from the system, and the control of the liver as a digestive organ. It contains normal and some particular digestive disorders, for example, colon polyps and Cancer, hepatitis, Gastroesophageal reflux (acid reflux), Ulcer related disorders, colitis, gallbladder, and biliary tract sickness, dietary issues, Irritable Bowel Syndrome (IBS), and pancreatitis. Expands, all basic action, and illness of the stomach related organs are a piece of the study of Gastroenterology.

Track 21: Gastrointestinal Immunology

The gastrointestinal tract plays dual roles in human physiology one is digestion and uptake of nutrients and another one is the more difficult task of maintaining immune homeostasis i.e protecting the body from harmful microbes. No other system has this unique architecture like functioning and regulating both the systems. The gastrointestinal-associated lymphoid tissue (GALT), which is composed of discrete inductive and effector sites, can differentiate between the harmful and harmless antigens while maintaining the homeostasis. Inductive sites are well organized into specialized gatherings of lymphoid follicles called Peyer's patches, while effector sites are more diffusely Separated. The separation of these sites serves to limit and control the immune responses. In addition to its Unique architecture, the GI tract has specialized immune cells that aid in promoting a tolerogenic response to orally introduced antigens, e.g. subsets of dendritic cells (DCs) and regulatory T-cells, which is produced in many quantities at mucosal surfaces, and it promotes and nurtures an anti-inflammatory environment by neutralizing immune stimulatory antigens.

Track 22: Gastrointestinal Surgery

Gastrointestinal Surgery is also known as Digestive System Surgery. GI surgery is a treatment for diseases of the parts of the body involved in digestion i.e Upper gastrointestinal and lower gastrointestinal. Upper Gastrointestinal Surgery includes the esophagus (ee-sof-uh-gus), liver, gallbladder, and pancreas. Lower gastrointestinal surgery will deal with the stomach, small intestine, Larger intestine, colon, rectum, anus.

Description

Recent Research on Liver Diseases in Japan:

A research team based at Tokyo Medical and Dental University (TMDU) has used an integrated data analysis to classify hepatocellular carcinoma, the most common type of liver cancer, into three distinct subgroups, which should aid targeted treatment

Tokyo, Japan – Liver cancer remains a major problem in healthcare globally, being the second most common cause of cancer-related death globally. Previous studies showed that this disease, especially its predominant form hepatocellular carcinoma (HCC), exhibits substantial heterogeneity. However, efforts to categorize HCC more precisely have been limited by an inability to integrate data from various sources into a single classification system.

A Tokyo Medical and Dental University (TMDU)-centered research group has made a major advance in this field by combining data on mutations, gene expression patterns, and immunological status to shed light on the variation among cases of HCC. The study, recently reported in the journal EBioMedicine, reveals that there are actually three distinct types of this disease, which should help in predicting the prognosis of individual patients and treating them more effectively.

Global Hepatology and Liver Diseases market (2018-2025)

The global Infectious Diseases and therapy on Liver market is expected to reach US$ 4,056.4 Mn in 2025 from US$ 2,011.2 Mn in 2017. The market is estimated to grow with a CAGR of 8.1% from 2018-2025.

The growth of the Liver Cancer therapy market is primarily attributed to the increase in the number of therapies launched in the market. The development of new drugs is thus expected to drive the growth of Liver diseases therapy mainly Liver Cancer market. For instance, in October 2015, the FDA approved the Onivyde drug by Merrimack Pharmaceuticals, Inc. as a part of treatment regimen for advanced cancer. Some common side effects associated with chemotherapy drugs include diarrhea and abdominal cramping, fatigue, loss of appetite, change in food taste and others. Cancer cells that are rapidly growing are killed by chemotherapy drugs.

Liver Disease Treatment Market Report has been published by Allied Market Research, forecasts that the global market is expected to reach $19,536 million by 2022, registering a CAGR of 11.72% during the period 2016 - 2022. The antiviral drug segment held a major share of the total market in 2015 and is expected to maintain its lead throughout the forecast period. This is attributed to the high incidences of virus-infected liver diseases including Hepatitis, which are genetically, immunologically, pathologically related. However, corticosteroid drug segment registered fastest growing segment during the forecast period.

The factors driving the liver disease treatment market are rapidly changing lifestyle patterns such as increasing consumption of alcohol, and unhealthy diets; and the increasing prevalence of liver diseases.

Key findings of liver Disease Treatment Market:

The Corticosteroids drug is projected to be the fastest growing segment, registering a CAGR of 16.49% during the forecast period
North America is expected to lead the market throughout 2022 and is projected to grow at a CAGR of 11.89%, during 2016 and 2022
Asia-Pacific is expected to grow with a CAGR of around 12.51%, due to the increasing prevalence of liver diseases and increasing R&D investments in this region

Hepatology Associations:

Liver Kids Australia
Children's Liver Disease Foundation (CLDF)
Hepatitis B Foundation
Hepatitis Foundation International
Asian Pacific Association for the Study of the Liver (APASL)
Hong Kong Liver Foundation - Hong Kong (HK), China
Immunization Action Coalition
International Liver Transplantation Society (ILTS)
Swiss Association for the Study of the Liver (SASL) - Switzerland (CH)
The Japan Society of Hepatology
The Asian Pacific Association for the Study of the Liver [APASL]
Hepatology Society of the Philippines
European Association for the Study of the Liver (EASL)
International Liver Cancer Association
American Association for the Study of Liver Diseases (AASLD)
The International Association for the Study of the Liver
Emirates Gastroenterology and Hepatology Society (EGHS)
The Egyptian Society of Hepatology, Gastroenterology and Infectious Diseases in Alexandria (ESHGID)
The 43rd European Society For Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)

Companies manufacturing Liver equipment’s

Echosens
KMC Systems
Argon Medical devices Inc
Hu medics
FDA approved drugs in 2016 for Hepatology
Defitelio
Ocaliva

List of Manufacturing Companies:

Bristol-Myers Squibb
GlaxoSmithKline
Gilead Sciences
Schering
Roche
Novartis
Vertex Pharmaceuticals
Three Rivers Pharma
Janssen Pharmaceuticals
AbbVie Inc.
Merck & Co.
Merck Sharp Dohme

Why Liver Diseases@ Tokyo, Japan

ETIQUETTE in Tokyo is a BIG Deal

Tokyo is an imperial city of Arts, City of Unique fashion..

Tokyo is the seventh most liveable city in the world. ... Coming in on the seventh place in the 'Most Liveable Cities' index, a tie with Toronto in Canada, Tokyo has made its highest ranking yet thanks to a decline in crime rates as well as a stable improvement in the city's public transportation system.

Tokyo is Japan's capital and the world's most swarmed city. It is in like the way one of Japan's 47 prefectures, including 23 focal city wards and distinctive urban domains, towns, and towns west of the downtown zone. The Izu and Ogasawara Islands are in like way parts of Tokyo.

Going before 1868, Tokyo was known as Edo. A little fortification town in the sixteenth century, Edo changed into Japan's political fixation in 1603 when Tokugawa Ieyasu built up his medieval government there.

A couple of decades later, Edo had shaped into one of the world's most swarmed urban zones. With the Meiji Restoration of 1868, the sovereign and capital moved from Kyoto to Edo, which was renamed Tokyo.

Enormous pieces of Tokyo were wrecked in the Great Kanto Earthquake of 1923 and distinguishable all around the strikes of 1945. Today, Tokyo offers a clearly boundless decision of shopping, intensity, culture and eating up to its guests.

The city's history can be perceived in the district, for example, Asakusa, and in different splendid introduction halls, basic safe houses and nurseries. In spite of ordinary astuteness, Tokyo besides offers diverse connecting with green spaces in the downtown locale and inside all around short prepare rides at its edges.

Tokyo Metropolis is settled inside the focal point of the Japanese archipelago inside the Kanto Region on the northwest of Tokyo Bay. It outskirts Edogawa River and Chiba Prefecture toward the east, mountains and Yamanashi Prefecture toward the west, Tama Igawa River and Kanagawa Prefecture toward the south, and Saitama Prefecture toward the north.

Metropolitan Tokyo is part of littler managerial bodies – the "focal" space, containing twenty-three wards.

Tokyo is famous for Anime, electronics, manga, and video games. Akihabara is the epicenter of it all. It becomes a jungle of electric lights and colors at night, providing a sensory overload for visitors. Getting lost, window shopping, and photography is top activities here.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	December 02-03, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View